Pregled bibliografske jedinice broj: 1253571
BPC 157 as a therapy for retinal ischemia induced by retrobulbar application of L-NAME in rats
BPC 157 as a therapy for retinal ischemia induced by retrobulbar application of L-NAME in rats // Frontiers in pharmacology, 12 (2021), 632295, 14 doi:10.3389/fphar.2021.632295 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1253571 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
BPC 157 as a therapy for retinal ischemia induced by retrobulbar application of L-NAME in rats
(BPC 157 as a therapy for retinal ischemia induced by
retrobulbar application of L-NAME in rats)
Autori
Zlatar, Mirna ; Kokot, Antonio ; Batelja Vuletić, Lovorka ; Masnec, Sanja ; Kralj, Tamara ; Milković Periša, Marija ; Barišić, Ivan ; Radić, Božo ; Milanović, Kristina ; Drmić, Domagoj ; Seiwerth, Sven ; Sikirić, Predrag
Izvornik
Frontiers in pharmacology (1663-9812) 12
(2021);
632295, 14
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
BPC 157 ; L-NAME ; ischemia ; rats ; retina
Sažetak
Providing NO-system importance, we suggest that one single application of the NOS-blocker L-NAME may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L- NAME application. A rat retinal ischemia study was conducted throughout 4 weeks, including fundoscopy, behavior presentation, tonometry, and histology assessment. Retrobulbar L-NAME application (5 mg/kg ; 0.5 mg/0.1 ml saline/each eye) in rats immediately produced moderate generalized irregularity in the diameter of blood vessels with moderate atrophy of the optic disc and faint presentation of the choroidal blood vessels, and these lesions rapidly progressed to the severe stage. The specific L-NAME-induced vascular failure points to normal intraocular pressure (except to very transitory increase upon drug retrobulbar administration). When BPC 157 (10 μg ; 10 ng/kg, as retrobulbar application, 1 μg ; 1 ng/0.1 ml saline/each eye) is given at either 20 min after L-NAME or, lately, at 48 h after L-NAME, the regular retrobulbar L-NAME injection findings disappear. Instead, fundoscopy demonstrated only discrete generalized vessel caliber irregularity with mild atrophy of the optic disc, and then, quite rapidly, normal eye background and choroidal blood vessels, which remain in all of the subsequent periods. Also, histology assessment at 1, 2, and 4 weeks shows that BPC 157 counteracted the damaged inner plexiform layer and inner nuclear layer, and revealed normal retinal thickness. The poor behavioral presentation was also rescued. Thus, while further studies will be done, BPC 157 counteracted L-NAME-induced rat retinal ischemia.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Medicinski fakultet, Osijek
Profili:
Antonio Kokot
(autor)
Sven Seiwerth
(autor)
Lovorka Batelja Vuletić
(autor)
Ivan Barišić
(autor)
Marija Milković Periša
(autor)
SANJA MASNEC
(autor)
Predrag Sikirić
(autor)
Kristina Milanović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus